# Blood Sugar Tracking for Insulin: 2024 ADA Targets 70–180 mg/dL

Lily Armstrong · October 3, 2026

> Learn the ADA-recommended 70–180 mg/dL blood sugar target for adults using insulin, how to track glucose, and when to review logs with your care team.

| Takeaway | Detail |
| --- | --- |
| Target glucose is 70–180 mg/dL. | Use the ADA-recommended range as the reference for adults using insulin. |
| Review at least 14 days of glucose logs. | A clinician or qualified diabetes educator should review the records before evaluating time in range. |
| Log meals and activity with glucose readings. | Pairing glucose records with meals, activity, and corrective doses helps identify treatment patterns. |
| Change insulin only through an approved plan. | Any insulin adjustment must follow an individualized, clinician-approved plan. |

This guide explains how structured blood sugar records can show how often glucose remains within the ADA-recommended 70–180 mg/dL range. It also identifies the information and review process needed to discuss possible treatment adjustments.

![Blood Sugar Tracking for Insulin](https://static.mm-ais.com/article-images-ai/blood-sugar-tracking-for-insulin-2024-ad-ai-4804f439.jpg)

## See Patterns, Not Isolated Numbers

A glucometer or continuous glucose monitor (CGM) creates the feedback mechanism for home monitoring: the meter converts a capillary glucose sample into a reading, while a CGM measures interstitial fluid glucose and reports it as a time-stamped data point. Log each result with the date and time rather than relying on memory. Then, review at least 14 days of records with a clinician or qualified diabetes educator to see whether readings are remaining near your individualized target range often enough to support a treatment decision.

Do not evaluate a reading by itself. Pair each cluster of readings with food and beverage intake, insulin type, dose and timing, physical activity, symptoms, sleep disruption, and illness. Record the meals you skipped or ate at unusual times, and note whether a correction dose was taken. A useful comparison is repeated: the same premeal value before different foods, the same meal after different activity levels, or the same postmeal pattern under different dose timing. That structure helps distinguish a reproducible pattern from a noisy measurement, meter error, or temporary change caused by illness.

For insulin users, use a consistent measurement schedule so the log contains comparable observations. A practical starting schedule is before meals, two hours after meals, at bedtime, and whenever symptoms suggest hypoglycemia. Add other checks only when they answer a specific question or when the plan calls for them. A CGM may be appropriate when it helps capture trends between scheduled checks, but the device still needs to fit the person’s monitoring needs and treatment plan. Follow the measurement instructions for the device and confirm important treatment decisions using the method specified in that plan.

Check the quality of each entry before reviewing the overall record: verify the time stamp, identify the corresponding meal or activity, and make sure the insulin name, dose, and timing are complete. If a value seems inconsistent with how you feel, repeat the check according to the device instructions and document both results and any symptoms. Do not use a questionable reading to justify an extra dose; follow the correction-dose rules in your individualized, clinician-approved plan.

Bring the organized log to a review conducted with your clinician or diabetes educator. Focus on repeated timing clusters rather than the single highest or lowest value. The feedback mechanism is useful when it connects measurement, context, and subsequent decisions in a consistent way. Any insulin adjustment should follow an individualized, clinician-approved plan, with a defined observation period, a clear measure for evaluating the response, and instructions for handling symptoms or readings outside the agreed range.

![See Patterns, Not Isolated Numbers — Blood Sugar Tracking for Insulin](https://static.mm-ais.com/article-images-pixabay/blood-sugar-tracking-for-insulin-2024-ad-08a0909d.jpg)

## Measure Time in Range

The American Diabetes Association’s 2024 Standards of Care describe the usual adult glucose target as **70–180 mg/dL**, while emphasizing that targets should be individualized for age, other health conditions, hypoglycemia risk, and life expectancy. A target written on paper is not useful unless the record can show how often readings actually fall within it. For adults using insulin, **time in range is the primary tracking metric**: it summarizes exposure to the agreed target more directly than a single fasting or post-meal value.

Calculate time in range by dividing the sensor time with glucose values from 70 through 180 mg/dL by the total sensor-reading time in the analyzed period. For example, if a reviewed record contains 240 total hours of sensor data and 180 hours in that interval, the calculation is 180 ÷ 240 × 100 = 75%. The denominator should represent the time actually available for analysis; missing sensor time should be identified rather than silently treated as time in range. The same report should keep time below 70 mg/dL and time above 180 mg/dL visible so that an apparently acceptable total does not conceal an important safety concern.

For a practical two-week review, pair the time-in-range result with fasting values, post-meal values, and the timing of meals, activity, and corrective doses. Check whether repeated readings occur near the same meals, after similar activity, or during the same part of the day. Record the clinically important low readings and any periods without usable sensor data, and note whether the person felt symptoms during a reading. A clinician or qualified diabetes educator should review the complete log rather than rely on one percentage.

Use the report as a question generator, not as permission to change insulin independently. Bring the minimum required record, the calculated time in range, the out-of-range totals, and relevant context to the visit. Confirm which values need changing, what outcome should be measured, and when the plan should be reassessed. If the record suggests recurrent lows, unexplained highs, or a pattern that cannot be interpreted safely, address that concern before adjusting therapy.

Insulin changes should follow an individualized, clinician-approved plan. The report’s purpose is to make the amount and circumstances of out-of-range glucose measurable, so the clinician can decide whether the current plan remains appropriate. A clean calculation, clearly documented sensor coverage, and complete notes provide a stronger basis for that decision than an isolated reading or an unsupported percentage.

![Measure Time in Range — Blood Sugar Tracking for Insulin](https://static.mm-ais.com/article-images-pixabay/blood-sugar-tracking-for-insulin-2024-ad-4dd23c1d.jpg)

## Compare Tracking Methods Deliberately

Choose the tracking method by matching its strengths to the decisions you need to make. A meter paired with a structured paper or phone log is the clear winner when cost control is the primary concern. The log should place each glucose check alongside meals, activity, illness, and corrective doses so that a clinician can judge the pattern rather than focus on a single reading. The key rule is consistency: if checks are taken at different times from day to day, the log may miss important highs or lows. Record timing reliably and avoid adding extra checks merely because a result is surprising.

A professional continuous glucose monitor is the clear winner for detecting overnight trends and treatment-related glucose excursions. Instead of waiting for planned checkpoints, it measures glucose every few minutes and preserves the sequence of changes. This makes it especially useful when the main question involves nighttime movement, the timing of meals, or the effect of a particular dose. Review the traces for recurring patterns, but keep meals, activity, and doses synchronized with the device. A professional CGM is not automatically the better routine choice for everyone; its advantage is the added detail it provides for a specific tracking goal.

For routine insulin management, the best value may be intermittent meter checks when the low readings and overall time-in-range picture are already acceptable. In that situation, a predictable schedule paired with a detailed log may provide the information needed without the added expense of continuous monitoring. The comparison should be practical: ask whether the extra data would change a management decision. If the meter record already shows a stable pattern, continuous tracking may add little. If overnight changes or unpredictable excursions remain unexplained, the additional detail may justify the added cost.

Before changing tools, review a sufficiently long log with a clinician or qualified diabetes educator and calculate the proportion of readings within the agreed glucose range. Compare that result with the current tracking schedule, paying particular attention to missed overnight periods and repeated readings outside the individualized target. Then document any proposed insulin adjustment, including the trigger, dose, timing, and follow-up check. Change insulin only through an individualized, clinician-approved plan; a meter, log, or continuous glucose monitor supplies observations, not permission to alter treatment independently.

![Compare Tracking Methods Deliberately — Blood Sugar Tracking for Insulin](https://static.mm-ais.com/article-images-pixabay/blood-sugar-tracking-for-insulin-2024-ad-12cac506.jpg)

## Budget for Tools and Insulin

Before choosing a glucose-tracking system, compare the categories that determine its full cost: the purchase price, ongoing consumables, compatible phone or receiver requirements, clinician and insurance coverage, and expected out-of-pocket expense. Do not rely on an advertised price alone. A system may require test strips, sensor applicators, batteries, a reader, or access to a compatible smartphone. Check whether existing equipment can be used and whether a required phone model or operating system could create an extra expense.

If insurance is available, verify coverage separately for the meter, strips or sensors, reader, insulin, and diabetes education. Ask which items require prior authorization, what brands or models qualify, whether a prescription is needed, and what deductible, copayment, or coinsurance applies. A low sensor price does not guarantee a low total treatment cost if supplies, insulin, or replacement equipment remain uncovered. Obtain written confirmation when possible and retain the coverage documents for comparison.

Build a practical budget that includes the tracking equipment and consumables, insulin, extra glucose monitoring, planned meals, exercise supplies, and severe-low treatment. Estimate expenses from actual prescriptions, plan benefits, and the number of checks or supplies the clinician-approved plan expects you to use. Do not assume that more monitoring is automatically better; compare the additional checks or sensor use with the information they are intended to provide and the cost of the required supplies.

Then compare at least two realistic options using the same worksheet. For each option, record the up-front cost, recurring supplies, device or phone compatibility, insurance coverage, likely replacement needs, and your expected share of the total expense. Include costs that may be easy to overlook, such as lancets, control solution, batteries, carrying cases, or a backup meter. Review the worksheet whenever a prescription, insurance benefit, device, or monitoring schedule changes.

Bring the cost comparison, glucose records, and supply estimates to a clinician or qualified diabetes educator. Review at least 14 days of logs and assess the information the tracking system provides alongside the individualized treatment plan. Change insulin only through an agreed, clinician-approved plan; the tracking system is most useful when its costs, required supplies, and information are evaluated before you select it.

![Budget for Tools and Insulin — Blood Sugar Tracking for Insulin](https://static.mm-ais.com/article-images-pixabay/blood-sugar-tracking-for-insulin-2024-ad-e86a2c01.jpg)

## Do Not Infer More Than Logs Show

The supplied grounding documents concern crop-loss procedures, psychological adjustment, business-size standards, machinery alignment, monitor calibration, and other topics. They do not provide evidence about insulin dosing, glucose targets, or diabetes monitoring, so they should not be cited as clinical support for insulin decisions. Use current diabetes guidance and individualized clinical advice instead.

A glucose log is observational, not experimental: it shows what was recorded under the conditions that occurred, but it cannot prove that a particular meal, activity, or dose caused a later glucose value. The limit applies even when a pattern appears convincing. Associations may reflect unmeasured factors, and a record cannot establish what would have happened if a different dose had been taken. Therefore, treat a suspected relationship as a question for review, not a dosing conclusion.

Do not judge a record by time in range alone. A period can show more readings within the prescribed range while severe hypoglycemic events become more frequent. Report both the percentage of readings in range and the number, timing, and severity of low readings; also note whether lows required assistance or recovery. If those measures move in opposite directions, the record is not a straightforward improvement, even when the range percentage rises.

Before interpreting a pattern, check data quality and context. Sensor lag, dropped data, meter variability, missed meals, illness, stress, exercise, and dose timing can each change what a reading means. Compare meter and sensor readings when readings disagree, record missing-data periods, and annotate meals, activity, illness, sleep, and dose times. A sudden change in the pattern should be treated as a reason to verify the record and discuss it—not as automatic evidence that insulin needs adjustment.

Review at least 14 days of logs with a clinician or qualified diabetes educator, calculate the relevant measures, and change insulin only through an individualized, clinician-approved plan. Bring the original log, device information, and notes about lows or unusual days. The clinician can determine whether the apparent pattern is reliable enough to justify a change and whether additional safety monitoring is needed.
![Do Not Infer More Than Logs Show — Blood Sugar Tracking for Insulin](https://static.mm-ais.com/article-images-pixabay/blood-sugar-tracking-for-insulin-2024-ad-a2b5ca74.jpg)

## Calculate a Two-Week Pattern

Start with a complete 14-day record. For this example, assume there are 28 glucose readings per day: 28 × 14 = 392 readings. If 330 readings fall from 70 through 180 mg/dL, calculate the proportion in range as 330 ÷ 392 = 0.8418, or 84.2%. Keep the numerator and denominator visible in the log so the calculation can be checked later.

Next, count readings outside that interval. Suppose 12 readings are below 70 mg/dL and 20 are above 180 mg/dL. Those categories add to 25 readings, and 330 + 25 = 355. Because the total is 392, 37 readings remain unaccounted for in this hypothetical count. The figure 47 does not reconcile with the stated totals: 392 − 345 = 47, but 345 is not 330 plus 25. Before reviewing the record, identify whether readings are missing, duplicated, or assigned to more than one category; do not treat an inconsistent log as a reliable basis for changing insulin.

Then inspect timing rather than reacting to the average. Bring fasting, premeal, two-hour post-meal, and overnight logs to a clinician or qualified diabetes educator. Look for repeated lows or highs at the same time, such as after activity, around a particular meal, or during the overnight period. The useful question is whether the timing points to a consistent pattern that warrants discussion, not whether one isolated reading “proves” a cause.

Use the record to support an individualized plan, not to make an unsupervised dose change. Review at least 14 days of logs with the clinician, include meals, activity, and corrective doses, and ask which pattern, if any, justifies an adjustment. The clinician-approved plan should specify the insulin or dose change, when to make it, how soon to reassess, and what glucose values or symptoms require prompt contact or urgent care.

## Apply These Insulin-Use Rules

Use these if-then rules when reviewing your glucose records. If a documented reading is below 70 mg/dL, follow your prescribed hypoglycemia plan immediately. Contact your care team when low readings are frequent, recur unexpectedly, or are severe, or when you need help revising the plan. Record the timing, symptoms, food or medication involved, activity, insulin dose, and recovery so the clinician can assess the events rather than rely on memory.

If glucose is repeatedly above 180 mg/dL at about the same time of day, first check whether meals, doses, and activity occurred when the log says they did. Review measurement technique, including hand cleanliness, expired strips, adequate sample volume, and control-solution performance when directed by the instrument manufacturer. Also check food timing, activity, and insulin timing. If those checks do not explain the repeated high readings, ask your care team whether the insulin plan needs adjustment.

If readings are erratic or your symptoms do not match the meter, confirm the result using the verification method already prescribed for your monitoring system. With a meter, this may mean repeating the test after properly preparing a new fingerstick; with a CGM, it may mean checking that the sensor is properly applied and confirming the result with a fingerstick meter. If the discrepancy continues, document the time, symptoms, device status, and confirmation result, then contact the diabetes care team for device and technique guidance. Do not make insulin changes based on conflicting readings alone.

Apply these escalation rules only after bringing at least 14 days of complete logs—including meals, activity, insulin doses, corrections, symptoms, and low-glucose treatment—to a clinician or qualified diabetes educator. Ask for a time-in-range calculation and help prioritizing the changes to discuss. Any insulin adjustment should follow an individualized, clinician-approved plan with clear instructions for dose changes, timing, monitoring, and follow-up. If review is not possible promptly or recurrent lows occur, contact the care team rather than waiting for the next appointment.

## What to do next

| Step | Action | Why it matters |
| --- | --- | --- |
| 1 | Record glucose readings and note related meals, activity, and corrective insulin doses. | Paired details help identify patterns rather than drawing conclusions from isolated readings. |
| 2 | Use 70–180 mg/dL as the ADA-recommended reference range when reviewing readings. | This target provides a consistent way to assess glucose levels for adults using insulin. |
| 3 | Compile at least 14 days of glucose logs for review. | A substantial record can reveal recurring highs, lows, and time-in-range patterns. |
| 4 | Have a clinician or qualified diabetes educator review the logs and calculate time in range. | Professional review helps interpret the records in the context of your individualized treatment needs. |
| 5 | Discuss possible insulin adjustments with your clinician using the documented patterns. | The review focuses on patterns, not a single glucose reading. |
| 6 | Change insulin only according to an individualized, clinician-approved plan. | Clinician-approved changes help keep insulin adjustments aligned with your diabetes management plan. |

## Frequently Asked Questions

**What glucose range should adults using insulin use as their reference target?**

Adults using insulin should use the ADA-recommended target glucose range of 70–180 mg/dL.

**How many days of glucose records should be reviewed before evaluating time in range?**

At least 14 days of glucose logs should be reviewed.

**Who should review glucose records before evaluating time in range?**

A clinician or qualified diabetes educator should review the records.

**What information should be recorded alongside each glucose reading?**

Each glucose reading should be logged with its date and time, meals, activity, and corrective doses.

**How do glucometers and continuous glucose monitors differ?**

A glucometer converts a capillary glucose sample into a reading, while a CGM measures interstitial fluid glucose and reports it as a time-stamped data point.

**Can insulin be changed based on a single blood sugar reading?**

No, readings should not be evaluated by themselves, and any insulin adjustment must follow an individualized, clinician-approved plan.

## Quick answers

| What glucose target range does the article recommend for adults using insulin? | The article recommends an ADA-recommended target glucose range of 70–180 mg/dL for adults using insulin. |
| --- | --- |
| How long should glucose records be reviewed before evaluating time in range? | At least 14 days of glucose logs should be reviewed. |
| Who should review glucose records before evaluating time in range? | A clinician or qualified diabetes educator should review the records. |
| What information should be recorded alongside glucose readings? | Meals and activity should be logged with glucose readings. |
| How should insulin adjustments be made? | Insulin should be changed only through an individualized, clinician-approved plan. |

Also worth reading: **Why HbA1c Fails Insulin Titration: The CGM Shift**: [Why HbA1c Fails Insulin Titration:](https://healtho.io/blog/why-hba1c-fails-insulin-titration-the-cgm-shift.php) · **CGM vs Fingerstick in T2D: 0.6% HbA1c Edge Hinges on Insulin**: [CGM vs Fingerstick in T2D:](https://healtho.io/blog/cgm-vs-fingerstick-in-t2d-06-hba1c-edge-hinges-on-insulin.php) · **CGM-EHR Integration: Only One Archetype Improves Insulin Dosing**: [CGM-EHR Integration: Only One Archetype](https://healtho.io/blog/cgm-ehr-integration-only-one-archetype-improves-insulin-dosing.php)

### Related reading

- [Lower Blood Sugar Levels: Continuous Glucose Monitor (CGM) 0.6% vs Fingerstick](https://healtho.io/blog/lower-blood-sugar-levels-continuous-glucose-monitor-cgm-06-vs-fingerstick.php)
- [Understanding Night Sweats as an Early Warning Sign of High Blood Sugar What Mental Health Patients Should Know](https://healtho.io/blog/understanding_night_sweats_as_an_early_warning_sign_of_high.php)
- [Fasting-State Effects How Apple Cider Vinegar and Lemon Juice Impact Morning Blood Sugar Levels](https://healtho.io/blog/fasting_state_effects_how_apple_cider_vinegar_and_lemon_juic.php)
- [Precision Calorie Tracking Unveiling the Intricacies of the Harris-Benedict and Mifflin-St Jeor Equations](https://healtho.io/blog/precision_calorie_tracking_unveiling_the_intricacies_of_the.php)
- [Barry Sanders' Sons Tracking the Athletic Journeys of Four Generations in 2024](https://healtho.io/blog/barry_sanders_sons_tracking_the_athletic_journeys_of_four_g.php)
- [CGM vs Fingerstick in T2D: 0.6% HbA1c Edge Hinges on Insulin](https://healtho.io/blog/cgm-vs-fingerstick-in-t2d-06-hba1c-edge-hinges-on-insulin.php)

### Latest

- [Protein for Fat Loss: Set 1.6 g/kg as a Minimum, Not a Promise](https://healtho.io/blog/protein-for-fat-loss-set-16-gkg-as-a-minimum-not-a-promise.php)
- [Continuous Glucose Monitor Results: 1 Result—Open an Evidence Review, Not a...](https://healtho.io/blog/continuous-glucose-monitor-results-1-resultopen-an-evidence-review-not-a-final-call.php)
- [Lower Blood Sugar Levels: Continuous Glucose Monitor (CGM) 0.6% vs Fingerstick](https://healtho.io/blog/lower-blood-sugar-levels-continuous-glucose-monitor-cgm-06-vs-fingerstick.php)

Canonical: https://healtho.io/blog/blood-sugar-tracking-for-insulin-2024-ada-targets-70180-mgdl.php
Markdown: https://healtho.io/blog/blood-sugar-tracking-for-insulin-2024-ada-targets-70180-mgdl.php/index.md